Table 2.
Quality assessment of included randomized controlled trials.
| Included trials | Random sequence generation | Allocation concealment | Blinding of participants and personnel | Blinding of outcome assessment | Incomplete outcome data | Selective reporting | Other sources of bias | Risk of bias |
|---|---|---|---|---|---|---|---|---|
| Liu et al., 2009 [30] | Unclear | Unclear | Unclear | Unclear | Yes | No | Unclear | High |
| Chen et al., 2006 [31] | Unclear | Unclear | Unclear | Unclear | Yes | No | Unclear | High |
| Ji and Han, 2011 [32] | Unclear | Unclear | Unclear | Unclear | Yes | No | Unclear | High |
| Yuan, 2006 [33] | Unclear | Unclear | Unclear | Unclear | Yes | No | Unclear | High |
| Shi, 2011 [34] | Unclear | Unclear | Unclear | Unclear | Yes | Yes | Unclear | High |
| Li and Wan, 2006 [35] | Unclear | Unclear | Unclear | Unclear | Yes | No | Unclear | High |
| Liang, 2011 [36] | Unclear | Unclear | Unclear | Unclear | Yes | No | Unclear | High |
| Fu and Xiao, 2011 [37] | Table of random number | Unclear | Unclear | Unclear | Yes | Yes | Unclear | Unclear |
| Yang et al., 2008 [38] | Unclear | Unclear | Unclear | Unclear | Yes | No | Unclear | High |
| Lin and Zhou, 2004 [39] | Unclear | Unclear | Unclear | Unclear | Yes | Yes | Unclear | High |
| Ai, 2012 [40] | Unclear | Unclear | Unclear | Unclear | Yes | Yes | Unclear | High |
| Qin, 2008 [41] | Unclear | Unclear | Unclear | Unclear | Yes | No | Unclear | High |